0001140361-13-046213.txt : 20131213
0001140361-13-046213.hdr.sgml : 20131213
20131213193135
ACCESSION NUMBER: 0001140361-13-046213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131211
FILED AS OF DATE: 20131213
DATE AS OF CHANGE: 20131213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KORMAN HARRY
CENTRAL INDEX KEY: 0001197548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 131277468
MAIL ADDRESS:
STREET 1: MYLAN LABORATORIES INC
STREET 2: 1718 NORTHROCK CT
CITY: ROCKFORD
STATE: IL
ZIP: 61103
4
1
doc1.xml
FORM 4
X0306
4
2013-12-11
0
0000069499
MYLAN INC.
MYL
0001197548
KORMAN HARRY
1500 CORPORATE DRIVE
CANONSBURG
PA
15317
0
1
0
0
Chief Operating Officer
Common Stock
2013-12-11
4
M
0
24898
21.13
A
141293
D
Common Stock
2013-12-11
4
S
0
24898
41.7504
D
116395
D
Common Stock
2013-12-11
4
M
0
15288
22.66
A
131683
D
Common Stock
2013-12-11
4
S
0
15288
41.8372
D
116395
D
Common Stock
2013-12-11
4
M
0
9814
23.44
A
126209
D
Common Stock
2013-12-11
4
S
0
9814
41.9437
D
116395
D
Common Stock
1001
I
By 401(k) Plan
Stock Option Right to Buy
21.13
2013-12-11
4
M
0
24898
0
D
2020-03-03
Common Stock
24898
4732
D
Stock Option Right to Buy
22.66
2013-12-11
4
M
0
15288
0
D
2021-03-02
Common Stock
15288
7644
D
Stock Option Right to Buy
23.44
2013-12-11
4
M
0
9814
0
D
2022-02-22
Common Stock
9814
48016
D
Represents the weighted average price of the reporting person's disposition of 24,898 shares in transactions ranging from $41.51 to $42.48.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 3, and 4 to this Form 4.
Represents the weighted average price of the reporting person's disposition of 15,288 shares in transactions ranging from $41.57 to $42.48.
Represents the weighted average price of the reporting person's disposition of 9,814 shares in transactions ranging from $41.70 to $42.48.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 22, 2013.
The options vested in three equal installments on March 3, 2011, 2012, and 2013.
Two-thirds of the options vested in equal installments on March 2, 2012 and 2013. The remainder of the options will vest on March 2, 2014.
One-third of the options vested on February 22, 2013. The remainder of the options will vest in equal installments on February 22, 2014 and 2015.
/s/ Harry Korman
2013-12-13